跳转到主内容

非常抱歉,我们不完全支持您的浏览器。如果您可以选择,请升级到较新版本或使用 Mozilla Firefox、Microsoft Edge、Google Chrome 或 Safari 14 或更高版本。如果您无法进行此操作且需要支持,请将您的反馈发送给我们。

全新设计的官网为您带来全新体验,期待您的反馈

Elsevier
通过我们出版

Profile

Jin-Quan Yu

Jin-Quan Yu

The Scripps Research Institute, USA

Rational-design and unexpected discovery of new reactions through C-H activation.

Our program centers around the discovery of catalytic carbon-carbon and carbon-heteroatom bond forming reactions based on C-H activation. Target transformations are selected to enable 1) the use of simple and abundant starting materials such as aliphatic acids, amines and alcohols, and 2) disconnections that drastically shorten the synthesis of drug molecules or a major class of biologically active compounds. Ultimately, we hope to develop catalytic reactions to parallel enzymatic transformations in terms of reactivity and selectivity. To achieve this goal, our research activities are directed towards the following main aspects: C-H activation, sustainable catalysis, asymmetric catalysis and synthetic applications.

Major components of training for students are organometallic chemistry, asymmetric catalysis (synthesis and characterization of organometallic complexes as catalysts or intermediates; ligand design for chiral control or acceleration) and organic synthesis (in the context of drug discovery and natural product synthesis). We collaborate extensively with computational groups via NSF center (Professor Jamal Musaev, Emory University, Professor Ken Houk, UCLA), as well as pharmaceutical and agrochemical industry (BMS and Syngenta) and Aldrich. We have research projects on the following topics: C-H activation (how to cleave C-H bonds without using forceful conditions?); Catalysis (how to close catalytic cycles under practical conditions?); and Synthetic applications (how to shorten synthetic routes for natural products and drug molecules?).